Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Alia A. Sagatova"'
Autor:
Alia A. Sagatova
Publikováno v:
Journal of Fungi, Vol 7, Iss 1, p 49 (2021)
Fungal pathogens present a challenge in medicine and agriculture. They also harm ecosystems and threaten biodiversity. The allylamine class of antimycotics targets the enzyme squalene monooxygenase. This enzyme occupies a key position in the sterol b
Externí odkaz:
https://doaj.org/article/4173b0c31d2840d39ef034cae0aa546b
Autor:
Joel D A Tyndall, Manya Sabherwal, Alia A Sagatova, Mikhail V Keniya, Jacopo Negroni, Rajni K Wilson, Matthew A Woods, Klaus Tietjen, Brian C Monk
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0167485 (2016)
Azole antifungals, known as demethylase inhibitors (DMIs), target sterol 14α-demethylase (CYP51) in the ergosterol biosynthetic pathway of fungal pathogens of both plants and humans. DMIs remain the treatment of choice in crop protection against a w
Externí odkaz:
https://doaj.org/article/ecc5305817ae4a19aa6dae4d47d44614
Autor:
Alia A. Sagatova
Publikováno v:
Journal of Fungi
Journal of Fungi, Vol 7, Iss 49, p 49 (2021)
Journal of Fungi, Vol 7, Iss 49, p 49 (2021)
Fungal pathogens present a challenge in medicine and agriculture. They also harm ecosystems and threaten biodiversity. The allylamine class of antimycotics targets the enzyme squalene monooxygenase. This enzyme occupies a key position in the sterol b
Autor:
Mikhail V. Keniya, Brian C. Monk, Manya Sabherwal, Joel D. A. Tyndall, Rajni K. Wilson, Alia A. Sagatova, Matthew A. Woods
Targeting lanosterol 14α-demethylase (LDM) with azole drugs provides prophylaxis and treatments for superficial and disseminated fungal infections, but cure rates are not optimal for immunocompromised patients and individuals with comorbidities. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32ffb49ea97e4543c1a09084e4be2874
https://europepmc.org/articles/PMC6201081/
https://europepmc.org/articles/PMC6201081/
Autor:
Rajni K. Wilson, Parham Hosseini, Mikhail V. Keniya, Brian C. Monk, Alia A. Sagatova, Yasmeen N. Ruma
Publikováno v:
Biochimica et biophysica acta. Proteins and proteomics. 1868(3)
The cytochrome P450 enzyme lanosterol 14α-demethylase (LDM) is the target of the azole antifungals used widely in medicine and agriculture as prophylaxis or treatments of infections or diseases caused by fungal pathogens. These drugs and agrochemica
Publikováno v:
Antimicrobial Agents and Chemotherapy. 62
Fungal infections frequently affect immunodeficient individuals and are estimated to kill 1.35 million people per annum. Azole antifungals target the membrane-bound cytochrome P450 monooxygenase lanosterol 14α-demethylase (CYP51; Erg11p). Mutations
Autor:
Brian C. Monk, Manya Sabherwal, Rajni K. Wilson, Joel D. A. Tyndall, Mikhail V. Keniya, Alia A. Sagatova
Publikováno v:
Scientific Reports
Emergence of fungal strains showing resistance to triazole drugs can make treatment of fungal disease problematic. Triazole resistance can arise due to single mutations in the drug target lanosterol 14α-demethylase (Erg11p/CYP51). We have determined
Autor:
Matthew A. Woods, Klaus Tietjen, Mikhail V. Keniya, Jacopo Negroni, Brian C. Monk, Manya Sabherwal, Joel D. A. Tyndall, Alia A. Sagatova, Rajni K. Wilson
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0167485 (2016)
PLoS ONE
PLoS ONE
Azole antifungals, known as demethylase inhibitors (DMIs), target sterol 14α-demethylase (CYP51) in the ergosterol biosynthetic pathway of fungal pathogens of both plants and humans. DMIs remain the treatment of choice in crop protection against a w
Publikováno v:
Antimicrobial agents and chemotherapy. 59(8)
Infections by fungal pathogens such as Candida albicans and Aspergillus fumigatus and their resistance to triazole drugs are major concerns. Fungal lanosterol 14α-demethylase belongs to the CYP51 class in the cytochrome P450 superfamily of enzymes.
Autor:
Lachowicz J; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, USA., Lee J; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, USA., Sagatova A; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, USA., Jew K; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, USA., Grove TL; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, USA. Electronic address: tyler.grove@einsteinmed.edu.
Publikováno v:
Current opinion in structural biology [Curr Opin Struct Biol] 2023 Dec; Vol. 83, pp. 102720. Date of Electronic Publication: 2023 Oct 18.